Skip to Main Content

Paper Details

Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States.
JCO Precis Oncol
93
2018
Author NameAffiliation
Stacy W GrayNational Cancer Institute , National Institutes of Health , National Human Genome Research Institute, Harvard Medical School and Brigham and Women's Hospital , Dana-Farber Cancer Institute, University of Vermont Health Network and the University of Vermont, Georgetown University, American Society of Clinical Oncology
Donna R RiveraNational Cancer Institute , National Institutes of Health , National Human Genome Research Institute, Harvard Medical School and Brigham and Women's Hospital , Dana-Farber Cancer Institute, University of Vermont Health Network and the University of Vermont, Georgetown University, American Society of Clinical Oncology
Deborah SchragNational Cancer Institute , National Institutes of Health , National Human Genome Research Institute, Harvard Medical School and Brigham and Women's Hospital , Dana-Farber Cancer Institute, University of Vermont Health Network and the University of Vermont, Georgetown University, American Society of Clinical Oncology
Jeffery P StruewingNational Cancer Institute , National Institutes of Health , National Human Genome Research Institute, Harvard Medical School and Brigham and Women's Hospital , Dana-Farber Cancer Institute, University of Vermont Health Network and the University of Vermont, Georgetown University, American Society of Clinical Oncology
  • 1 - 4

Datasets